R. Cervera, M. Abarca-costalago, and D. Abramovicz, Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project, Autoimmun Rev, vol.5, issue.3, pp.180-186, 2006.

R. Cervera, M. A. Khamashta, and J. Font, Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore), vol.82, pp.299-308, 2003.

F. A. Houssiau, C. Vasconcelos, D. Cruz, and D. , The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

, Ann Rheum Dis, vol.69, issue.1, pp.61-64, 2010.

I. M. Bajema, S. Wilhelmus, and C. E. Alpers,

/. Nephrology and . Renal, Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices, Kidney Int, vol.93, issue.4, pp.789-796, 2018.

J. J. Weening, The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited, J Am Soc Nephrol, vol.15, issue.2, pp.241-250, 2004.

G. K. Bertsias, M. Tektonidou, and Z. Amoura, Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis, Ann Rheum Dis, vol.71, issue.11, pp.1771-1782, 2012.

T. Dörner and R. Furie, Novel paradigms in systemic lupus erythematosus. The Lancet, vol.393, pp.2344-2358, 2019.

J. Narváez, M. Ricse, and M. Gomà, The value of repeat biopsy in lupus nephritis flares: Medicine (Baltimore), vol.96, p.7099, 2017.

S. Bataille, N. Jourde, and L. Daniel, Comparative safety and efficiency of five percutaneous kidney biopsy approaches of native kidneys: a multicenter study, Am J Nephrol, vol.35, issue.5, pp.387-393, 2012.

S. Soliman and C. Mohan, Lupus nephritis biomarkers, Clin Immunol Orlando Fla, vol.185, pp.10-20, 2017.

G. Gulati, M. R. Bennett, and K. Abulaban, Prospective validation of a novel renal activity index of lupus nephritis, Lupus, vol.26, issue.9, pp.927-936, 2017.

A. Kitagawa, N. Tsuboi, and Y. Yokoe, Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis, Kidney Int, vol.95, issue.3, pp.680-692, 2019.

Y. Ding, L. Nie, and Y. Pang, Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis, Lupus, vol.27, issue.11, pp.1778-1789, 2018.

J. Klein, C. Lacroix, and C. Caubet, Fetal Urinary Peptides to Predict Postnatal Outcome of Renal Disease in Fetuses with Posterior Urethral Valves (PUV), Mol Cell Proteomics MCP, vol.5, issue.11, pp.2424-2437, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00853060

C. Pontillo, Z. Zhang, and J. P. Schanstra, Prediction of Chronic Kidney Disease Stage 3

. By-ckd273,-a-urinary-proteomic and . Biomarker, Kidney Int Rep, vol.2, issue.6, pp.1066-1075, 2017.

S. A. Varghese, T. B. Powell, and M. N. Budisavljevic, Urine biomarkers predict the cause of glomerular disease, J Am Soc Nephrol JASN, vol.18, issue.3, pp.913-922, 2007.

X. Zhang, J. M. Wu, and H. , Biomarkers of lupus nephritis determined by serial urine proteomics, Kidney Int, vol.74, issue.6, pp.799-807, 2008.

M. Suzuki, G. F. Ross, and K. Wiers, Identification of a urinary proteomic signature for lupus nephritis in children, Pediatr Nephrol Berl Ger, vol.22, issue.12, pp.2047-2057, 2007.

M. Suzuki, K. Wiers, and E. B. Brooks, Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis, Pediatr Res, vol.65, issue.5, pp.530-536, 2009.

J. C. Oates, S. Varghese, and A. M. Bland, Prediction of urinary protein markers in lupus nephritis, Kidney Int, vol.68, issue.6, pp.2588-2592, 2005.

K. Mosley, F. Tam, R. J. Edwards, J. Crozier, C. D. Pusey et al., Urinary proteomic profiles distinguish between active and inactive lupus nephritis, Rheumatol Oxf Engl, vol.45, issue.12, pp.1497-1504, 2006.

M. Pejchinovski, J. Siwy, and W. Mullen, Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus, Lupus, vol.27, issue.1, pp.6-16, 2018.

M. C. Hochberg, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, vol.40, issue.9, p.1725, 1997.

M. Petri, A. Orbai, and G. S. Alarcón, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, vol.64, issue.8, pp.2677-2686, 2012.

A. S. Levey, J. Coresh, and T. Greene, Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate, Ann Intern Med, vol.145, issue.4, p.247, 2006.

M. Haas, The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations, Am J Transplant, vol.16, issue.5, pp.1352-1357, 2016.

D. Theodorescu, S. Wittke, and M. M. Ross, Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis, p.11

H. Mischak, A. Vlahou, and J. Ioannidis, Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience, Clin Biochem, vol.46, issue.6, pp.432-443, 2013.

J. Klein, T. Papadopoulos, H. Mischak, W. Mullen, . Comparison et al.,

, MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine, ELECTROPHORESIS, vol.35, issue.7, pp.1060-1064, 2014.

P. Zürbig, M. B. Renfrow, and E. Schiffer, Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation, ELECTROPHORESIS, vol.27, issue.11, pp.2111-2125, 2006.

R. Wei, B. Gao, and F. Shih, Alterations in urinary collagen peptides in lupus nephritis subjects correlate with renal dysfunction and renal histopathology, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.32, issue.9, pp.1468-1477, 2017.

M. Lindhardt, F. Persson, and P. Zürbig, Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study, Nephrol Dial Transplant, p.292, 2016.

J. Klein, J. Bascands, H. Mischak, and J. P. Schanstra, The role of urinary peptidomics in kidney disease research, Kidney Int, p.7, 2016.

C. P. Mavragani, G. E. Fragoulis, G. Somarakis, A. Drosos, A. G. Tzioufas et al., Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis: Medicine (Baltimore), vol.94, p.829, 2015.

J. M. Mejia-vilet, S. V. Parikh, and H. Song, Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare, Nephrol Dial Transplant, vol.34, issue.7, pp.1197-1206, 2019.

S. Almaani, S. D. Prokopec, and J. Zhang, Rethinking Lupus Nephritis Classification on a Molecular Level, J Clin Med, vol.8, issue.10, p.1524, 2019.

D. Birmingham, F. Irshaid, and H. Nagaraja, The complex nature of serum C3 and C4 as biomarkers of lupus renal flare, Lupus, vol.19, issue.11, pp.1272-1280, 2010.

C. C. Mok, K. Y. Ying, and S. Tang, Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis, Arthritis Rheum, vol.50, issue.8, pp.2559-2568, 2004.

M. D. Linnik, J. Z. Hu, and K. R. Heilbrunn, Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus, Arthritis Rheum, vol.52, issue.4, pp.1129-1137, 2005.

A. J. Steiman, D. D. Gladman, D. Ibañez, M. B. Urowitz, . Acronim et al., Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome, Arthritis Res Ther, vol.37, issue.9, p.238, 2010.

D. Rosa, M. Azzato, F. Toblli, and J. E. , A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy, Kidney Int, vol.94, issue.4, pp.788-794, 2018.

G. J. Piñeiro, P. Arrizabalaga, M. Solé, R. M. Abellana, G. Espinosa et al., Repeated Renal Biopsy -A Predictive Tool to Assess the Probability of Renal Flare in Lupus Nephritis, Am J Nephrol, vol.44, issue.6, pp.439-446, 2016.

, Serment d'Hippocrate

, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux. Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur

, J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité

, Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Reçu à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je préserverai l'indépendance nécessaire à l'accomplissement de ma mission

, Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonoré et méprisé si j'y manque